Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine

Clinical trial NCT01702337 · COMPLETED

Trial details

NCT number: NCT01702337
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Human Papillomavirus Infection

Start date: 2010-02-01
Primary completion: 2010-02-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.